Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Selkoe

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Lancet. Neurology|June 17, 2019
β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?Dennis Selkoe
Harvard Health Letter|October 3, 2002
Alzheimer's disease: Conversation with an expertDennis Selkoe
Plos Biology|July 21, 2022
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?Christian Haass, Dennis Selkoe
Annual Review of Neuroscience|May 6, 2003
Notch and Presenilin: regulated intramembrane proteolysis links development and degenerationDennis Selkoe, Raphael Kopan
Nature Reviews. Neurology|October 1, 2025
Parkinson disease is a fatty acidopathySaranna Fanning, Dennis Selkoe
Science (New York, N.Y.)|August 25, 2022
News story miscasts Alzheimer's scienceDennis Selkoe, Jeffrey Cummings
Acta Neuropathologica|July 2, 2020
Vesicle trafficking and lipid metabolism in synucleinopathySaranna Fanning, Dennis Selkoe, Ulf Dettmer
The New England Journal of Medicine|July 25, 2019
Verubecestat for Prodromal Alzheimer's DiseaseShaomin Li, Lei Liu, Dennis Selkoe
Cold Spring Harbor Perspectives in Medicine|February 9, 2012
Deciphering Alzheimer diseaseDennis Selkoe, Eckhard Mandelkow, David Holtzman
NPJ Parkinson'S Disease|January 8, 2020
Parkinson's disease: proteinopathy or lipidopathy?Saranna Fanning, Dennis Selkoe, Ulf Dettmer
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Lancet. Neurology|June 17, 2019
β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?Dennis Selkoe
Harvard Health Letter|October 3, 2002
Alzheimer's disease: Conversation with an expertDennis Selkoe
Plos Biology|July 21, 2022
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?Christian Haass, Dennis Selkoe
Annual Review of Neuroscience|May 6, 2003
Notch and Presenilin: regulated intramembrane proteolysis links development and degenerationDennis Selkoe, Raphael Kopan
Nature Reviews. Neurology|October 1, 2025
Parkinson disease is a fatty acidopathySaranna Fanning, Dennis Selkoe
Science (New York, N.Y.)|August 25, 2022
News story miscasts Alzheimer's scienceDennis Selkoe, Jeffrey Cummings
Acta Neuropathologica|July 2, 2020
Vesicle trafficking and lipid metabolism in synucleinopathySaranna Fanning, Dennis Selkoe, Ulf Dettmer
The New England Journal of Medicine|July 25, 2019
Verubecestat for Prodromal Alzheimer's DiseaseShaomin Li, Lei Liu, Dennis Selkoe
Cold Spring Harbor Perspectives in Medicine|February 9, 2012
Deciphering Alzheimer diseaseDennis Selkoe, Eckhard Mandelkow, David Holtzman
NPJ Parkinson'S Disease|January 8, 2020
Parkinson's disease: proteinopathy or lipidopathy?Saranna Fanning, Dennis Selkoe, Ulf Dettmer
Pageof 4